About
Nanological develops a diagnostic device that enables ultra-rapid identification of sepsis-causing pathogens directly from blood samples without the need for culture or labeling, using optomechanical detection and AI to support clinical decision-making.
Explore Nanological's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.